Russell Investments Group Ltd. Sells 31,598 Shares of Humana Inc. (NYSE:HUM)

Key Points

• Russell Investments Group Ltd. reduced its stake in Humana Inc. by 7.0%, selling 31,598 shares and now holding 422,474 shares worth approximately $111.8 million.
• Humana's stock recently opened at $275.17 and experienced a 3.2% rise, with a market cap of $33.1 billion.
• Humana reported revenue growth of 9.6% year-over-year, with quarterly earnings of $6.27 per share, which missed analysts' expectations by $0.05.

Russell Investments Group Ltd. cut its position in Humana Inc. (NYSE:HUM - Free Report) by 7.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 422,474 shares of the insurance provider's stock after selling 31,598 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.35% of Humana worth $111,786,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Cary Street Partners Investment Advisory LLC increased its position in Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after acquiring an additional 46 shares in the last quarter. Riverview Trust Co bought a new position in Humana in the first quarter valued at approximately $34,000. Garde Capital Inc. acquired a new position in Humana during the first quarter worth $36,000. Zions Bancorporation National Association UT acquired a new position in Humana during the first quarter valued at approximately $37,000. Finally, Transce3nd LLC bought a new position in shares of Humana in the 4th quarter valued at about $38,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Oppenheimer upped their price objective on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a report on Thursday, May 1st. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 target price on shares of Humana in a research report on Thursday, May 1st. Truist Financial reduced their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Piper Sandler reduced their target price on shares of Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research report on Thursday, July 31st. Finally, Argus reaffirmed a "hold" rating and set a $281.99 price objective on shares of Humana in a research report on Thursday. Eighteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $281.45.

Humana Stock Up 1.9%

Shares of HUM traded up $5.39 during trading hours on Friday, reaching $286.73. The stock had a trading volume of 1,738,591 shares, compared to its average volume of 1,736,875. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a 50-day simple moving average of $241.58 and a 200 day simple moving average of $253.94. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $382.72. The company has a market capitalization of $34.49 billion, a price-to-earnings ratio of 22.01, a P/E/G ratio of 1.66 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%. The company's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.96 earnings per share. Equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.